FIELD: medicine. SUBSTANCE: agent containing bifidobacteria has additionally lysozyme at amount 5-20 mg per one preparation dose and bifidobacteria amount is $$$ colony-forming units (CFU). Use of the proposed preparation ensures to decrease recovery by 1.5-2-fold and provides the enhancement of different clinical indices. Preparation can be used orally, locally and intravaginally (2.5-15 doses for 1-3 weeks) in children in adult. EFFECT: enhanced effectiveness of agent.
